Founded in 2006, Staatz Consulting is a strategic and operational partner in Business Development and Market Access consulting, working with a broad client basis from the international (USA, Europe, Asia) biotechnology, pharmaceutical, medtech and investment industry.

We provide Transaction Advisory Services on the sell and the buy side. Our track-record of transactions comprises all customary agreement types and geographies (global, regional, local) in a broad variety of indication areas with a head-line value exceeding US$ 4.2 bn in total to date. Our success is based on our experienced senior consultants with more than 25 years industry experience each. We benefit from our wide industry network, thorough preparation, efficient and structured operational management and skilled negotiation.

Our Market Access team provides strategic and operative Market Access expertise predominantly for Europe combining scientific capabilities with a deep knowledge of payer decision frameworks as well as Health Technology Assessment (HTA) processes. We cover all developmental stages in a broad range of indications.

We excel in the thorough assessment of the competitive and HTA landscape, the development of compelling value positions for your product, evidence guidance matching payer expectations, clinical trial design for HTA purposes, payer research and Early Scientific HTA advice, as well as successful Market Access operations including value, JCA and HTA dossiers and payer negotiations.